Skip to main navigation Skip to search Skip to main content

In vitro synthesis of antibodies to acetylcholine receptor by Epstein-Barr virus-stimulated B-lymphocytes derived from patients with myasthenia gravis

  • Talma Brenner
  • , Yael Timore
  • , Itzhak Wirguin
  • , Oded Abramsky
  • , Michael Steinitz

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Peripheral blood lymphocytes and B-cells were obtained from patients with myasthenia gravis and stimulated in vitro with either pokeweed mitogen or Epstein-Barr virus (EBV), respectively. EBV stimulation of B-cells caused a production of antibodies to acetylcholine receptor in 15 of the 25 myasthenia gravis patients: the EBV stimulation of B-cells was more effective in this regard than the pokeweed mitogen stimulation of peripheral blood lymphocytes. The in vitro synthesis of anti-acetylcholine receptor antibodies was found to be positively correlated with both the patient's sera antibody titers and with the disease severity.

Original languageEnglish
Pages (from-to)217-222
Number of pages6
JournalJournal of Neuroimmunology
Volume24
Issue number3
DOIs
StatePublished - 1 Jan 1989
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-acetylcholine receptor antibody
  • Autoantibody, production in vitro
  • Epstein-Barr virus-transformed B lymphocyte
  • Myasthenia gravis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'In vitro synthesis of antibodies to acetylcholine receptor by Epstein-Barr virus-stimulated B-lymphocytes derived from patients with myasthenia gravis'. Together they form a unique fingerprint.

Cite this